MeCo Diagnostics
About:
Biomarker-enabled drug repurposing for cancer
Website: https://mecodiagnostics.com/
Top Investors: GoAhead Ventures, Team Ignite Ventures
Description:
Medtech company developing predictive biomarker technology to empower a new modality of low-toxicity cancer therapy
Total Funding Amount:
$500000
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2022-03-09
Contact Email:
adam(AT)mecodiagnostics.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai